{"entity":{"type":"insider","cik":"0001643127","url":"/insider/0001643127","json_url":"/insider/0001643127.json","name":"Krop Julie","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2016-10-20","last":"2026-06-24","span_basis":"filed_date"},"name_variants":[{"name":"Krop Julie","source":"filing","n_filings":5,"first_seen":"2016-10-20","last_seen":"2026-06-24"}],"transactions":[{"id":5860513,"accession":"0001214659-26-007677","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-26-007677","line_url":"/filing/0001214659-26-007677#line-2","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001643127","owner_name":"Krop Julie","owner_url":"/insider/0001643127","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":5.0157,"price_display":"5.02","price_state":"stated","total_value":125392.5,"total_display":"125,392.50","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-23","filed_date":"2026-06-24","scope":"insider"},{"id":8305282,"accession":"0000792977-19-000113","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000792977-19-000113","line_url":"/filing/0000792977-19-000113#line-1","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001643127","owner_name":"Krop Julie","owner_url":"/insider/0001643127","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":9.91,"price_display":"9.91","price_state":"stated","total_value":99100.0,"total_display":"99,100.00","shares_owned_after":81399.0,"shares_owned_after_display":"81,399","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-28","filed_date":"2019-05-29","scope":"insider"},{"id":4773268,"accession":"0001179110-17-010382","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-17-010382","line_url":"/filing/0001179110-17-010382#line-1","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001643127","owner_name":"Krop Julie","owner_url":"/insider/0001643127","role":"Officer (SVP Clinical & Regulatory, CMO)","officer_title":"SVP Clinical & Regulatory, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4938.0,"shares_display":"4,938","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":98760.0,"total_display":"98,760.00","shares_owned_after":28336.0,"shares_owned_after_display":"28,336","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-13","filed_date":"2017-07-14","scope":"insider"},{"id":4856427,"accession":"0001179110-17-006402","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-17-006402","line_url":"/filing/0001179110-17-006402#line-1","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001643127","owner_name":"Krop Julie","owner_url":"/insider/0001643127","role":"Officer (SVP Clinical & Regulatory, CMO)","officer_title":"SVP Clinical & Regulatory, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1891.0,"shares_display":"1,891","price_per_share":24.45,"price_display":"24.45","price_state":"stated","total_value":46234.95,"total_display":"46,234.95","shares_owned_after":36777.0,"shares_owned_after_display":"36,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-01","filed_date":"2017-05-02","scope":"insider"},{"id":2124811,"accession":"0001179110-16-030835","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-16-030835","line_url":"/filing/0001179110-16-030835#line-1","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001643127","owner_name":"Krop Julie","owner_url":"/insider/0001643127","role":"Officer (SVP Clinical & Regulatory, CMO)","officer_title":"SVP Clinical & Regulatory, CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4938.0,"shares_display":"4,938","price_per_share":24.8,"price_display":"24.80","price_state":"stated","total_value":122462.4,"total_display":"122,462.40","shares_owned_after":23668.0,"shares_owned_after_display":"23,668","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-20","filed_date":"2016-10-20","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001398733","name":"Aquestive Therapeutics, Inc.","url":"/issuer/0001398733","role":"Director","n_filings":1,"first_seen":"2026-06-24","last_seen":"2026-06-24"},{"type":"issuer","type_label":"ISSUER","cik":"0000792977","name":"AMAG PHARMACEUTICALS INC.","url":"/issuer/0000792977","role":"Officer (Chief Medical Officer)","n_filings":4,"first_seen":"2016-10-20","last_seen":"2019-05-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001643127","retrieved_at":"2026-08-22T00:33:08+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}